Mirati Therapeutics made several changes to the executive management team as the company continues to accelerate the development of its KRAS and sitravatinib programs through registrational trials and prepares for commercialization.

Ross Quinn joined the FCB Health Network as director of customer solutions.

Compugen Ltd. appointed Oliver Froescheis, Ph.D., as senior VP, corporate and business development.

AlzeCure Pharma AB appointed Martin Jönsson as the company’s new CEO.

Jim Wassil was appointed chief operating officer of SutroVax.

Stuart Hughes was named CEO of Pathios Therapeutics Ltd.

Jaydev Thakkar was named chief operating officer and Milan Shah was appointed chief technology officer of Biofourmis

Relative to doctors who were shown rational ads that were generalized, the third annual Wunderman Thompson Health Inertia Study found that 34 percent more doctors were likely to take action after seeing emotional ads that addressed them on a personal level.

One key issue for healthcare brands that many of us know about and have seen firsthand is keeping marketing and sales teams in complete alignment as the brand message is developed and then rolled out in the field. In the race to get positive marketplace momentum going there can be a disconnect that develops in what we call the “passing of the baton” from marketing to sales. It’s when, even after all the work, time, creativity, analysis, and testing that goes into brand development, somehow a gap arises, or the timing is off as the proverbial brand “baton” is passed to the sales force.

TikTok: it’s the new social video app, it’s everywhere, and it’s the next generation of video.